c-Met expression in primary tumors and their corresponding distant metastases

Molecular Medicine Reports

Volumn 1, Issue 6, 2008, Pages 787-790

  Isaksson Mettävainio, Martin ^a   Van Guelpen, Bethany ^a   Öberg, Åke ^a   Stenling, Roger ^a   Palmqvist, Richard ^a   Henriksson, Maria L ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

c Met; Colorectal cancer; Metastasis

Indexed keywords

SCATTER FACTOR RECEPTOR;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CLINICAL EVALUATION; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOGENESIS; PRIMARY TUMOR; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILCOXON SIGNED RANKS TEST;

EID: 69249142658     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000029     Document Type: Article

References (22)

1. Hurle RA, Davies G, Parr C, Mason MD, Jenkins SA, Kynaston HG and Jiang WG: Hepatocyte growth factor/scatter factor and prostate cancer: a review. Histol Histopathol 20: 1339-1349, 2005. (Pubitemid 41489177)
2. Takanami I, Tanana F, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T and Kodaira S: Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers. Oncology 53: 392-397, 1996. (Pubitemid 26283782)
3. Alami J, Williams BR and Yeger H: Expression and localization of HGF and met in Wilms' tumours. J Pathol 196: 76-84, 2002.
4. Herynk MH, Stoeltzing O, Reinmuth N, Parikh NU, Abounader R, Laterra J, Radinsky R, Ellis LM and Gallick GE: Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Res 63: 2990-2996, 2003. (Pubitemid 36667174)
5. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A and Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992.
6. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P and Comoglio PM: Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6: 1997-2003, 1991.
7. Kataoka H, Hamasuna R, Itoh H, Kitamura N and Koono M: Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res 60: 6148-6159, 2000. (Pubitemid 30839648)
8. Takeuchi H, Bilchik A, Saha S, Turner R, Wiese D, Tanaka M, Kuo C, Wang HJ and Hoon DS: c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin Cancer Res 9: 1480-1488, 2003. (Pubitemid 36418405)
9. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF and Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991. (Pubitemid 21926175)
10. Brinkmann V, Foroutan H, Sachs M, Weidner KM and Birchmeier W: Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol 131: 1573-1586, 1995. (Pubitemid 26001760)
11. Birchmeier C, Birchmeier W, Gherardi E and Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925, 2003.
12. Weidner KM, Behrens J, Vandekerckhove J and Birchmeier W: Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111: 2097-2108, 1990. (Pubitemid 20361315)
13. De Wever O, Nguyen QD, van Hoorde L, Bracke M, Bruyneel E, Gespach C and Mareel M: Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18: 1016-1018, 2004. (Pubitemid 39561510)
14. Hiscox SE, Hallett MB, Puntis MC, Nakamura T and Jiang WG: Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers. Cancer Invest 15: 513-521, 1997. (Pubitemid 28015594)
15. Di Renzo MF, Olivero M, Giacomini A, et al: Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154, 1995.
16. Otte JM, Schmitz F, Kiehne K, Stechele HU, Banasiewicz T, Krokowicz P, Nakamura T, Folsch UR and Herzig K: Functional expression of HGF and its receptor in human colorectal cancer. Digestion 61: 237-246, 2000. (Pubitemid 30418224)
17. Fujita S and Sugano K: Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases. Jpn J Clin Oncol 27: 378-383, 1997. (Pubitemid 127519258)
18. Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R and Lidereau R: Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 339: 139-143, 1992.
19. Furukawa T, Duguid WP, Kobari M, Matsuno S and Tsao MS: Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol 147: 889-895, 1995.
20. Corso S, Comoglio PM and Giordano S: Cancer therapy: can the challenge be MET? Trends Mol Med 11: 284-292, 2005.
21. Miyata Y, Kanetake H and Kanda S: Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma. Clin Cancer Res 12: 4876-4881, 2006. (Pubitemid 44338574)
22. Arteaga CL: Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7: 31-39, 2002.